Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma
β Scribed by John S. Lam; Oleg Shvarts; Jonathan W. Said; Allan J. Pantuck; David B. Seligson; Michael E. Aldridge; Matthew H. T. Bui; Xueli Liu; Steve Horvath; Robert A. Figlin; Arie S. Belldegrun
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 164 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Angiogenesis is essential for the growth of solid tumors. intratumoral microvessel count, which represents a measure of tumor angiogenesis, has been associated with the overall survival of patients with a variety of malignancies. however, little is known about the significance of neo
Matrix-metalloproteinases (MMPs) are associated with invasive and metastatic behavior of several human malignant tumors. We have determined MMP-2 and MMP-9 and tissue inhibitors of MMPs (TIMP-1 and TIMP-2) in blood plasma and in renal tissue samples of patients with renal cell carcinoma (RCC) from c
Tumor-associated trypsin inhibitor (TATI) is a 6-kDa peptide, which is identical to the pancreatic-secretory-trypsin inhibitor (PSTI). TATI is produced by several tumors and cancer cell lines, and is used as a serum marker for mucinous ovarian cancer. Elevated serum levels of TATI have also been obs